Skip to content

Tissue Oxygen Use With Combined Arteriovenous Noninvasive Oximetry

Bedside Tissue Oxygenation Monitoring With Noninvasive Jugular Venous Oximetry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06072755
Acronym
TOUCAN-1
Enrollment
20
Registered
2023-10-10
Start date
2024-01-11
Completion date
2024-07-25
Last updated
2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxygen Consumption

Keywords

intensive care, jugular vein catheter, radial artery catheter

Brief summary

The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins. Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.

Detailed description

TOUCAN-1 is a study to estimate the accuracy and precision of pulse oximetry as a noninvasive tool for oxygen consumption measurement. Researchers will use a pair of commercially-available, noninvasive pulse oximeters to estimate the oxygen saturation of blood in the internal jugular vein, and compare it to the directly measured oxygen saturation in sampled jugular blood. Researchers will then measure the arterial oxygen saturation in a finger, and compare it to the directly measured oxygen saturation in sampled radial arterial blood.

Interventions

DEVICEFinger pulse oximetry probe

This finger probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

DEVICETransreflectance oximetry probe

This neck probe will be used to make noninvasive measurements of systemic arterial and central venous oxygen saturations.

Sponsors

AABB Foundation
CollaboratorUNKNOWN
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inpatient at the University of Wisconsin University Hospital * Has an internal jugular venous central line * Has a radial arterial line

Exclusion criteria

* Currently receiving extracorporeal membrane oxygenation (ECMO) * Currently receiving continuous renal replacement therapy (CRRT/CVVH) * All usable lumens of the participant's jugular catheter are in use, and interruption of any medical or therapy through any lumen would, in the view of the primary care team, compromise the participant's care. * Jugular venous catheter is not functional or position is not confirmed by radiography * Arterial cannula is not functional * Known history of sickle cell anemia or other hemoglobinopathy * Therapy with any of the following medications: * Nitroprusside * Hydroxocobalamin * Indocyanine green * Norepinephrine * Vasopressin * Epinephrine * Any other medication or therapy that, in the judgement of the study investigators, may affect the accuracy and precision of the noninvasive oximetry results

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of digital pulse oximetryThrough study completion, approximately 20 minutesDifference in the standard deviation of the arteriovenous saturation difference comparing noninvasive photoplethysmography to invasive blood sampling and oximetry
Accuracy of jugular pulse oximetryThrough study completion, approximately 20 minutesDifference in the standard deviation of the arteriovenous saturation difference comparing noninvasive photoplethysmography to invasive blood sampling and oximetry

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026